Navigation Links
Pharmaceutical Institute Hires Nathan Pienkowski, Ph.D., to Head Instructional Design
Date:12/15/2010

RALEIGH, N.C., Dec. 15, 2010 /PRNewswire/ -- Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance, has appointed Nathan Pienkowski, Ph.D., as Instructional Design Director.  In this role, Mr. Pienkowski will oversee the instructional quality of Pharmaceutical Institute's customized and commercially available courses within the industry's largest catalog of specialized training solutions.

Mr. Pienkowski has 15 years experience in course development, training, and learning technology development within the healthcare and pharmaceutical industry.  Prior to joining the Pharmaceutical Institute, Mr. Pienkowski served as a senior-level management consultant and principal of a consulting firm dedicated to education and training.  While there, he managed the development of custom training solutions for many of the industry's leading drug companies.

"Nathan's outstanding instructional design background, coupled with his track record of success as a high-level training consultant within pharma and biotech, is an exceptional fit," says Garry O'Grady, Senior Vice President and General Manager of Pharmaceutical Institute.  "To meet the next-level training needs of our clients, we seek only the best talent.  We are confident that Nathan will contribute to the enrichment and expansion of Pharmaceutical Institute's leading-edge course offerings."

Mr. Pienkowski received his doctorate and master's degree in Instructional Systems Design, as well as a bachelor's degree, from Virginia Polytechnic Institute and State University (Virginia Tech).

About the Pharmaceutical Institute

Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry.  We partner with subject matter experts from our parent company, Campbell Alliance, to develop high-impact
'/>"/>

SOURCE Pharmaceutical Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 E-QURE Corp (OTCQB: EQUR), ... live at VirtualInvestorConferences.com on July 9, 2015. ... http://tinyurl.com/e-qure-presentation This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:7/6/2015)... July 6, 2015 Array BioPharma,s (NASDAQ: ... this past weekend at the 2015 ESMO World ... At the meeting, data were shared from a ... 100-patient randomized Phase 2 expansion of that trial ... EGFR inhibitor, with or without the addition of ...
(Date:7/6/2015)... and SOUTH SAN FRANCISCO, Calif. ... (NYSE: AGN ), a leading global pharmaceutical company, ... developing novel treatments for dry eye disease, today announced ... Allergan will acquire Oculeve in an all-cash transaction.  Under ... for a $125 million upfront payment and commercialization milestone ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4
... JERUSALEM, Jan. 11 IDenta Corp. (PinkSheets: IDTA) announced today ... a General Screening Explosive Identifier. , This kit has been ... ampoules it contains, the following substances can be identified with ... Identifier.. , Ampoule 1: TNT, DNT, Tetryl. , Ampoule ...
... LAGUNA BEACH, California, January 11 Advanced ... announced today that it has completed a $5 million ,Series,B, ... venture,capital firm specialized in medical technology investments, and is expected,to ... was founded in 2007 to develop a novel irrigated radiofrequency,cardiac ...
Cached Medicine Technology:International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier 2International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier 3Advanced Cardiac Therapeutics Completes $5 Million Financing 2Advanced Cardiac Therapeutics Completes $5 Million Financing 3
(Date:7/6/2015)... ... July 06, 2015 , ... ... $400,000 in grant funds to support a three-year effort to reduce rates of ... will be conducted in partnership with the Morehouse School of Medicine’s Prevention Research ...
(Date:7/6/2015)... ... July 06, 2015 , ... Orthopaedic & ... his 100th case using SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on ... VA. The procedure was an L5-S1 posterior lumbar interbody fusion on a 69 ...
(Date:7/5/2015)... ... July 06, 2015 , ... ... market, is excited to announce the next generation of PrimeStar Individual Dental Insurance. ... to now include two network options—Maximum Allowable Charge (MAC) and usual, customary and ...
(Date:7/5/2015)... ... 2015 , ... Women’s Excellence in Wellness, powered by Movestrong is ... special consists of 2 months of unlimited classes for just $65. Student ID is ... 1410 South Lapeer Road in Lake Orion. , Women’s Excellence is ...
(Date:7/4/2015)... NY (PRWEB) , ... July 04, 2015 , ... Chronic ... 15% of chronic pain sufferers have pain located in the neck. Another 19% suffer ... the neck. Chiropractic literature suggests that 45% of American workers must deal ...
Breaking Medicine News(10 mins):Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3
... Moms and Babies, Bad for Mercury Fear,Campaign, WASHINGTON, ... for pregnant women, issued this morning by,the National Healthy ... at the nonprofit Center for Consumer Freedom,made the following ... and mercury swung back in the,direction of common sense. ...
... a departure from,current FDA and EPA guidelines, an ... childbearing age to increase their seafood,consumption, despite the ... other contaminants commonly found in seafood., "It,s ... fish without,mentioning the documented public health risks associated ...
... PRINCETON, N.J., Oct. 4 The following is a,statement ... their health information online:, It is encouraging that ... develop personal health record (PHR) products and systems,that people ... we,hope more companies will follow suit. Having ready access ...
... fired for managing diabetes at work but whose ... before House Judiciary,Subcommittee about his experience, ALEXANDRIA, ... reiterated its strong support for the ADA,Restoration Act, ... landmark,1990 Americans with Disabilities Act. On Thursday, the ...
... Psychemedics Corporation,(AMEX: PMD ) today announced that ... Controller. Jennifer will be responsible for all ... the financial analysis and planning,activities necessary for the ... Chairman and CEO. Since 1999, Jennifer has ...
... My Diabetes Connector, provides patients with virtual diabetes health- ... ... The American,Diabetes Association today unveiled a new web-based diabetes tool ... care providers -- to,share and organize important health information to ...
Cached Medicine News:Health News:Consumer Group Statement on Seafood and Health: 'We Told You So' 2Health News:Statement Regarding Microsoft's Announcement of New Services to Help People Store Their Health Information Online 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 2Health News:American Diabetes Association Urges Congress to Pass ADA Restoration Act, Help End Employment Discrimination Against Americans with Diabetes 3Health News:Jennifer Chmieleski Joins Psychemedics Corporation as Top Financial Officer 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 2Health News:New Diabetes Tool Available on American Diabetes Association Web Site 3Health News:New Diabetes Tool Available on American Diabetes Association Web Site 4
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
For connection to the bipolar output of electrosurgical generators....
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... for orthopedic procedures. Molded armrests ... 24" for the surgeon's comfort. ... to any O.R. table. Split ... and stability. Optional post or ...
Medicine Products: